Literature DB >> 6846393

Presumed respiratory syncytial virus pneumonia in three immunocompromised adults.

G J Kasupski, W D Leers.   

Abstract

Three cases of presumed respiratory syncytial virus (RSV) pneumonia in immunocompromised adults are described. Two patients had symptoms of cough, fever, and malaise, following completion of a course of combination chemotherapy for the treatment of acute lymphoblastic leukemia. The third patient, a juvenile onset diabetic, developed similar symptoms while hospitalized for severe hyperglycemia. Chest roentgenograms showed lower lobe infiltrates in both leukemic patients and a bilateral non-confluent bronchopneumonia in the diabetic patient. All patients had a marked rise in complement-fixing antibody titres to RSV, suggesting a concurrent infection with the virus. Extensive microbiological investigations failed to reveal any other etiologic agent. Nosocomial infection was considered possible. RSV is not considered a cause of pneumonia in compromised adults. Our three cases suggest that there may be a higher incidence of RSV pneumonia in compromised patients, than previously recognized.

Entities:  

Mesh:

Year:  1983        PMID: 6846393      PMCID: PMC7119426          DOI: 10.1097/00000441-198305000-00005

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  29 in total

1.  SEROLOGICAL EVIDENCE OF INFECTION BY RESPIRATORY SYNCYTIAL VIRUS IN OUTBREAK OF ACUTE BRONCHIOLITIS.

Authors:  P B CRONE; J B HEYCOCK; T C NOBLE; J B PATTON
Journal:  Br Med J       Date:  1964-06-13

2.  Respiratory syncytial virus. I. Virus recovery and other observations during 1960 outbreak of bronchiolitis, pneumonia, and minor respiratory diseases in children.

Authors:  R M CHANOCK; H W KIM; A J VARGOSKO; A DELEVA; K M JOHNSON; C CUMMING; R H PARROTT
Journal:  JAMA       Date:  1961-05-27       Impact factor: 56.272

3.  Natural reinfection of adults by respiratory syncytial virus. Possible relation to mild upper respiratory disease.

Authors:  K M JOHNSON; H H BLOOM; M A MUFSON; R M CHANOCK
Journal:  N Engl J Med       Date:  1962-07-12       Impact factor: 91.245

4.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. 3. Composite analysis of eleven consecutive yearly epidemics.

Authors:  C D Brandt; H W Kim; J O Arrobio; B C Jeffries; S C Wood; R M Chanock; R H Parrott
Journal:  Am J Epidemiol       Date:  1973-11       Impact factor: 4.897

5.  Respiratory syncytial virus infections in families. A study of family members of children hospitalized for acute respiratory disease.

Authors:  B Berglund
Journal:  Acta Paediatr Scand       Date:  1967-07

6.  Repeated infections with respiratory syncytial virus.

Authors:  M Beem
Journal:  J Immunol       Date:  1967-06       Impact factor: 5.422

7.  Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus.

Authors:  C L Lamprecht; H E Krause; M A Mufson
Journal:  J Infect Dis       Date:  1976-09       Impact factor: 5.226

8.  Development of in vitro correlates of cell-mediated immunity to respiratory syncytial virus infection in humans.

Authors:  R Scott; A Kaul; M Scott; Y Chiba; P L Ogra
Journal:  J Infect Dis       Date:  1978-06       Impact factor: 5.226

9.  Epidemiology of respiratory syncytial virus infection among infants and children in Chicago.

Authors:  M A Mufson; H D Levine; R E Wasil; H E Mocega-Gonzalez; H E Krause
Journal:  Am J Epidemiol       Date:  1973-08       Impact factor: 4.897

10.  Nosocomial respiratory syncytial virus infections.

Authors:  C B Hall; R G Douglas; J M Geiman; M K Messner
Journal:  N Engl J Med       Date:  1975-12-25       Impact factor: 91.245

View more
  2 in total

Review 1.  Respiratory syncytial virus. Brief review.

Authors:  E J Stott; G Taylor
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

2.  Pneumonias in adults due to mycoplasma, chlamydiae, and viruses.

Authors:  J P Luby
Journal:  Am J Med Sci       Date:  1987-07       Impact factor: 2.378

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.